Evidence map›Paper›PMID 24772331›Full record

ArticleActa naturae2014

Development of immunoassays using interferometric real-time registration of their kinetics.

A V Orlov, A G Burenin, V O Shipunova, A A Lizunova, B G Gorshkov, P I Nikitin

Abstract read
In one paragraph

Article in Acta naturae, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A V OrlovProkhorov General Physics Institute, Russian Academy of Sciences, Vavilov Str., 38, 119991, Moscow, Russia ; Moscow Institute of Physics and Technology, Institutskiy per., 9, 141700, Moscow Region, Dolgoprudny, Russia.
A G BureninProkhorov General Physics Institute, Russian Academy of Sciences, Vavilov Str., 38, 119991, Moscow, Russia ; Moscow Institute of Physics and Technology, Institutskiy per., 9, 141700, Moscow Region, Dolgoprudny, Russia.
V O ShipunovaMoscow Institute of Physics and Technology, Institutskiy per., 9, 141700, Moscow Region, Dolgoprudny, Russia.
A A LizunovaMoscow Institute of Physics and Technology, Institutskiy per., 9, 141700, Moscow Region, Dolgoprudny, Russia.
B G GorshkovProkhorov General Physics Institute, Russian Academy of Sciences, Vavilov Str., 38, 119991, Moscow, Russia.
P I NikitinProkhorov General Physics Institute, Russian Academy of Sciences, Vavilov Str., 38, 119991, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A method for effective development of solid-phase immunoassays on a glass surface and for optimization of related protocols by highly sensitive quantitative monitoring of each assay step has been proposed and experimentally implemented. The method is based on the spectral correlation interferometry (SCI) that allows real-time measuring of the thickness of a biomolecular layer bound to the recognition molecular receptors on the sensor chip surface. The method is realized with compact 3-channel SCI-biosensors that employ as the sensor chips standard cover glass slips without deposition of any additional films. Different schemes for antibody immobilization on a glass surface have been experimentally compared and optimized toward a higher sorption capacity of the sensor chips. Comparative characterization of the kinetics of each immunoassay stage has been implemented with the optimized protocols: i) covalent immobilization of antibody on an epoxylated surface and ii) biotinylated antibody sorption on a biotinylated surface via a high-affinity biotin-streptavidin bond. We have shown that magnetic nanoparticles employed as labels with model detection of cardiac troponin I further amplify the SCI signal, resulting in 100-fold improvement of the detection limit. The developed protocols can also be used with the alternative immunoassay platforms, including the label methods based on registration of only the final assay result, which is the quantity of bound labels.

Indexed as

cardiac troponin Iefficiency of biomolecular immobilizationimmunoassayinterferometryLabel-free biosensorsmagnetic nanoparticlessensor chipssurface biotinylationsurface epoxylationsurface functionalization

Identifiers

PMID24772331
PMCPMC3999470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.